Avantor, Inc.
AVTR · XNYSCIK 1722482fmd_18KYX8C9GDF7VAKJEPET0ZWC8ZManufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 36 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1,247 | 5,864 | 6,040 | 6,394 | 7,386 | 7,512 | 6,967 | 6,784 | 6,552 |
| Cost of revenue | 815 | 4,045 | 4,120 | 4,313 | 4,883 | 4,910 | 4,603 | 4,504 | 4,413 |
| Gross profit | 433 | 1,820 | 1,921 | 2,081 | 2,503 | 2,603 | 2,364 | 2,279 | 2,139 |
| Selling, general and administrative | 450 | 1,405 | 1,369 | 1,374 | 1,531 | 1,473 | 1,507 | 1,641 | 1,596 |
| Operating income | (210) | 414 | 552 | 707 | 972 | 1,130 | 696 | 1,085 | (246) |
| Interest expense | 201 | 524 | 440 | 308 | 217 | 266 | 285 | 219 | 170 |
| Other non-operating income (expense) | 8 | (4) | 3 | 10 | 11 | (1) | 6 | (1) | (21) |
| Income before taxes | (460) | (114) | 41 | 62 | 753 | 851 | 411 | 854 | (441) |
| Income tax expense | (315) | (27) | 3 | (54) | 180 | 165 | 89 | 142 | 89 |
| Net income from continuing operations | (145) | (87) | 38 | 117 | 573 | 687 | 321 | 712 | (530) |
| Net income | (113) | (87) | 38 | 117 | 573 | 687 | 321 | 712 | (530) |
| Net income to common shareholders | (415) | (356) | (335) | 52 | 508 | 662 | 321 | 712 | (530) |